More Than 800 Surgeons Viewed and Attended Demonstrations of SPORT(TM) Technology

/EINPresswire.com/ -- TORONTO, ON--(Marketwired - March 21, 2016) -  Titan Medical Inc. (TSX: TMD) (OTCQX: TITXF), a medical device company focused on the design and development of a robotic surgical system for a wide variety of minimally invasive surgery (MIS) procedures, today reported the successful unveiling of its SPORT™ Surgical System to surgical community audiences at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) meeting last week in Boston. Over the course of three exhibit days, more than 800 surgeons viewed the technology and attended live demonstrations of Titan's SPORT™ technology.

John Hargrove, Chairman and Chief Executive Officer of Titan Medical, said, "In my 40 years in the medical device industry, I have never experienced such a turnout and expression of interest as the Titan team did at SAGES. This was our first unveiling of the SPORT™ Surgical System as well as demonstration of its capabilities. The overwhelming feedback from the surgical community at SAGES visiting our exhibit was that SPORT™ could enable a new era of clinically capable, operationally efficient and ROI friendly robotic surgery."

About Titan Medical Inc.

Titan Medical Inc. is a Canadian public company focused on the design and development of a robotic surgical system for application in minimally invasive surgery ("MIS"). The Company's SPORT™ Surgical System, currently under development, includes a surgeon-controlled robotic platform that incorporates a 3D high-definition vision system and multi-articulating instruments for performing MIS procedures through a single incision. The surgical system also includes a surgeon workstation that provides a surgeon with an advanced ergonomic interface to the robotic platform for controlling the instruments and provides a 3D high-definition endoscopic view of inside a patient's body. The SPORT™ Surgical System is designed to enable surgeons to perform a broad set of surgical procedures for general abdominal, gynecologic, and urologic indications. For more information, visit the Company's website at www.titanmedicalinc.com.

Forward-Looking Statements

This news release contains "forward-looking statements" which reflect the current expectations of management of the Company's future growth, results of operations, performance and business prospects and opportunities. Wherever possible, words such as "may", "would", "could", "will", "anticipate", "believe", "plan", "expect", "intend", "estimate", "potential for" and similar expressions have been used to identify these forward-looking statements. These statements reflect management's current beliefs with respect to future events and are based on information currently available to management. Forward-looking statements involve significant risks, uncertainties and assumptions. Many factors could cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, without limitation, those listed in the "Risk Factors" section of the Company's Annual Information Form dated March 31, 2015 (which may be viewed at www.sedar.com). Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward looking statements prove incorrect, actual results, performance, or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this news release. These factors should be considered carefully, and prospective investors should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in the news release are based upon what management currently believes to be reasonable assumptions, the Company cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements. The SPORT system has not been approved for sale in the United States.

CONTACT INFORMATION

Titan Medical Inc.

John Hargrove, Chairman & Chief Executive Officer
(416) 548-7522 (ext. 151)
john.hargrove@titanmedicalinc.com
www.titanmedicalinc.com

EVC Group, Inc.

Todd Kehrli
tkehrli@evcgroup.com
(310) 625-4462

Michael Polyviou
mpolyviou@evcgroup.com
646-445-4800

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.